Company Search:
Advanced Search
Sponsored Links
Zhejiang Yatai Pharmaceutical Co.,Limited Company Snapshot
Zhejiang Yatai Pharmaceutical Co.,Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Yatai Pharmaceutical Co.,Limited with three other companies in this sector in China: Hybio Pharmaceutical Co Ltd (2016 sales of 855.05 million Chinese Renmimbi [US$135.81 million] of which 100% was Medical and Pharmaceutical Manufacturing), Anhui Anke Biotechnology (Group) Company., Limited (849.19 million Chinese Renmimbi [US$134.88 million] of which 57% was Biological Products), and Tianjin Lisheng Pharmaceutical Company Limited (846.83 million Chinese Renmimbi [US$134.50 million] of which 100% was Phamaceutical Manufacturing).

Sales Analysis. Zhejiang Yatai Pharmaceutical Co.,Limited reported sales of 862.87 million Chinese Renmimbi (US$137.05 million) for the year ending December of 2016. This represents an increase of 86.3% versus 2015, when the company's sales were 463.13 million Chinese Renmimbi. This was the third consecutive year of growth at Zhejiang Yatai Pharmaceutical Co.,Limited. Sales of Cro Service saw an increase that was more than double the company's growth rate: sales were up 764.5% in 2016, from 53.37 million Chinese Renmimbi to 461.33 million Chinese Renmimbi. Not all segments of Zhejiang Yatai Pharmaceutical Co.,Limited experienced an increase in sales in 2016: sales of Pharmaceutical Manufacturing Industry fell 2.0% to 400.84 million Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zhejiang Yatai Pharmaceutical Co.,Limited
  Stock Performance Chart for Zhejiang Yatai Pharmaceutical Co.,Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 18.97
(Figures in Chinese Renmimbi)
1 Week 7.8%   13 Weeks 2.6%  
4 Weeks 34.8%   52 Weeks 26.5%  
Zhejiang Yatai Pharmaceutical Co.,Limited Key Data:
  Ticker: 002370 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 862,874,547
(Year Ending Jan 2017).
Employees: 896
  Currency: Chinese Renmimbi Market Cap: 10,177,299,830
  Fiscal Yr Ends: December Shares Outstanding: 536,494,456
  Share Type: A Gu Closely Held Shares: 383,078,876
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.